Catherine R. Kinney - 14 Dec 2021 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anna Nazarenko, Authorized Signer
Issuer symbol
MET
Transactions as of
14 Dec 2021
Net transactions value
+$16,294
Form type
4
Filing time
16 Dec 2021, 15:35:01 UTC
Previous filing
02 Dec 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $16,294 +268 +0.51% $60.80 52,636 14 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.